Investigational new drugMitochondrial Peptide
Compound 62152
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062152
Risk Class
HIGH
Last Audit
Jan 31, 2109
Research Abstract
Mitochondrial Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 62152 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062152 with updates logged 2109-01-31.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-62152Mitochondrial Peptide Program 62152
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062152
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62152